Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
7.28
+0.03 (0.41%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Tempest Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tempest Therapeutics stock have an average target of 30, with a low estimate of 9.00 and a high estimate of 65. The average target predicts an increase of 312.09% from the current stock price of 7.28.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Tempest Therapeutics stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Scotiabank | Scotiabank | Buy → Hold Downgrades $91 → $9 | Buy → Hold | Downgrades | $91 → $9 | +23.63% | Apr 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $16 | Strong Buy → Hold | Downgrades | $16 | +119.78% | Apr 10, 2025 |
Scotiabank | Scotiabank | Buy Maintains $169 → $91 | Buy | Maintains | $169 → $91 | +1,150.00% | Mar 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $611 → $208 | Strong Buy | Maintains | $611 → $208 | +2,757.14% | Mar 28, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $104 → $65 | Buy | Maintains | $104 → $65 | +792.86% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.06
from -19.50
EPS Next Year
-1.31
from -1.06
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.84 | -0.71 | -0.93 | ||
Avg | -1.06 | -1.31 | -1.57 | ||
Low | -1.42 | -2.08 | -2.21 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.